CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Profitability  


Profitability by Company within Biotechnology & Pharmaceuticals Industry


Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Abbvie Inc 3 Q 69.39 % 22.17 % 25.35 % 56.92 %
American Bio Medica Corporation 3 Q 30.13 % - 1.79 % -
Acorda Therapeutics inc 3 Q 57.71 % - - -
Aclaris Therapeutics Inc 3 Q 33.76 % - - -
Acasti Pharma Inc 3 Q - - - -
Adaptimmune Therapeutics Plc 2 Q - - - -
Adagio Therapeutics Inc 3 Q - - - -
Adma Biologics Inc 3 Q - - - -
Adverum Biotechnologies Inc 3 Q - - - -
Aerie Pharmaceuticals Inc 3 Q 73.05 % - - -
Agenus Inc 3 Q 99.68 % 70.08 % 72.34 % -
Allergan plc 1 Q 82.71 % 10.51 % - -
Applied Genetic Technologies Corp 3 Q - - - -
Akoya Biosciences Inc 3 Q 62.73 % - - -
Aligos Therapeutics Inc 3 Q - - - -
Blue Biofuels Inc 3 Q - - - -
Allena Pharmaceuticals Inc 3 Q - - - -
Allovir Inc 3 Q - - - -
Ainos Inc 3 Q 71.45 % - 25.68 % -
Amgen Inc 3 Q - - - 63.73 %
Amyris Inc 3 Q 15.91 % - - -
Alpha Network Alliance Ventures Inc 3 Q 33.32 % - 5.47 % -
Apollo Endosurgery inc 2 Q 54.92 % - - -
Cellect Biotechnology Ltd 4 Q - - - 120.69 %
Aptose Biosciences Inc 3 Q - - - -
Aptevo Therapeutics Inc 3 Q - - - -
Armata Pharmaceuticals Inc 3 Q - - - -
Aslan Pharmaceuticals Ltd 4 Q - - - -
Assembly Biosciences inc 3 Q - - - -
Athira Pharma Inc 3 Q - - - -
Atara Biotherapeutics Inc 3 Q - - - -
Avantor Inc 3 Q 33.58 % 8.55 % 65.56 % 16.87 %
Anavex Life Sciences Corp 3 Q - - - 0.69 %
Axim Biotechnologies Inc 3 Q - - - -
Axcella Health Inc 3 Q - - - -
Axon Enterprise inc 3 Q 62.32 % 20.92 % 6.6 % -
Ayala Pharmaceuticals Inc 3 Q - - - -
Aytu Biopharma inc 3 Q 56.88 % - - -
Aziyo Biologics inc 3 Q 32.12 % - - -
Brickell Biotech Inc 3 Q - - - -
Bioatla Inc 3 Q - - - -
Brainstorm Cell Therapeutics inc 3 Q - - - -
Biocryst Pharmaceuticals Inc 3 Q 98.56 % - - -
Black Diamond Therapeutics Inc 3 Q - - - -
Beam Therapeutics Inc 3 Q - - - -
Biogen Inc 3 Q 81.58 % 11.45 % - 19.39 %
Bionovate Technologies Corp 3 Q - - - -
Berkeley Lights Inc 3 Q 63.37 % - - -
Bluebird Bio Inc 2 Q - - - -
Bionano Genomics Inc 3 Q 24.79 % - - -
Biontech Se 4 Q 87.7 % 3.15 % - 1.11 %
Organicell Regenerative Medicine Inc 2 Q 90.05 % - - -
Biorestorative Therapies Inc 2 Q - - - -
Nanomix Corporation 3 Q - - - -
Brooklyn Immunotherapeutics Inc 3 Q - - - -
Biondvax Pharmaceuticals Ltd 4 Q - - - -
Cabaletta Bio Inc 2 Q - - - -
Candel Therapeutics Inc 3 Q - - - -
General Cannabis Corp 4 Q 20.33 % - 12 % -
Capricor Therapeutics inc 3 Q - - - -
Casi Pharmaceuticals inc 3 Q 77.43 % - - -
Cannabis Global Inc 4 Q 19.94 % 66.67 % 10.21 % -
Catalyst Biosciences Inc 3 Q - - - -
Cellular Biomedicine Group Inc 3 Q 76.41 % - - -
C4 Therapeutics Inc 3 Q - - - -
Codiak Biosciences Inc 3 Q - - - -
Cidara Therapeutics Inc 3 Q - - - -
Chromadex Corporation 3 Q 61.12 % - - -
Cardax Inc 1 Q 63.3 % - 37.74 % -
Creative Medical Technology Holdings Inc 3 Q 60 % - - -
Cen Biotech Inc 3 Q - - 74.57 % -
Compugen Ltd 4 Q 97 % - - -
Coherus Biosciences inc 3 Q 74.21 % - 37.33 % -
Cellectis S a 4 Q 50.95 % - - -
Checkmate Pharmaceuticals Inc 3 Q - - - -
Compass Therapeutics Inc 3 Q - - - -
Cell Medx Corp 3 Q 72.85 % - - -
Cannabics Pharmaceuticals Inc 4 Q - - - -
Cocrystal Pharma Inc 3 Q - - - -
Cannapharmarx Inc 3 Q - - - -
Caribou Biosciences Inc 3 Q - - - -
Cardiff Oncology inc 3 Q - - - -
Curis Inc 3 Q - - - -
Crispr Therapeutics Ag 3 Q - - - 19.19 %
Clarus Therapeutics Holdings Inc 3 Q 88.1 % - - -
American Cryostem Corporation 3 Q - - - -
Champions Oncology Inc 3 Q 52.41 % 2.35 % 6.64 % 5.06 %
Cytek Biosciences Inc 3 Q 61.89 % 1.01 % - -
Cytomx Therapeutics Inc 3 Q - - - -
Citius Pharmaceuticals Inc 3 Q - - - -
Cue Biopharma Inc 3 Q - - - -
Cel sci Corporation 3 Q - - - -
Cv Sciences Inc 3 Q 46.17 % - - -
Cyanotech Corp 3 Q 39.94 % 10.3 % 11.39 % 12.03 %
Cytodyn inc 4 Q 76.89 % - - -
Cytrx Corporation 3 Q - - - -
Dbv Technologies S a 3 Q - - - -
Diffusion Pharmaceuticals Inc 3 Q - - - -
Ginkgo Bioworks Holdings Inc 3 Q 95.58 % - - -
Codex Dna Inc 3 Q 41.71 % - - -
Denali Therapeutics Inc 3 Q - - - -
Dyadic International Inc 3 Q 43.35 % - - 23.56 %
Eargo Inc 2 Q 71.76 % - - -
Emergent Biosolutions Inc 3 Q 68.63 % - - 15.04 %
Eidos Therapeutics Inc 3 Q - - - -
Eiger Biopharmaceuticals Inc 3 Q 89.54 % - - -
Elevation Oncology inc 3 Q - - - -
Eloxx Pharmaceuticals Inc 3 Q - - - -
Endonovo Therapeutics Inc 3 Q 60.17 % - - -
Enzon Pharmaceuticals inc 3 Q - - - -
Erytech Pharma S a 4 Q - - - -
Establishment Labs Holdings Inc 3 Q 67.56 % - - -
89bio Inc 3 Q - - - -
Evelo Biosciences Inc 3 Q - - - -
Eyenovia inc 3 Q - - - -
Fate Therapeutics Inc 3 Q - - - -
4d Molecular Therapeutics Inc 3 Q - - - -
Fennec Pharmaceuticals Inc 3 Q - - - -
Homology Medicines Inc 3 Q - - - -
Fulgent Genetics Inc 3 Q 80.92 % 53.64 % 50.21 % 68.21 %
Forma Therapeutics Holdings Inc 3 Q - - - -
Finch Therapeutics Group Inc 3 Q - - - -
Frequency Therapeutics Inc 3 Q - - - -
Fusion Pharmaceuticals Inc 3 Q - - - -
Gilead Sciences Inc 3 Q 83.52 % 34.85 % - 37.61 %
Monte Rosa Therapeutics Inc 3 Q - - - -
Genocea Biosciences Inc 3 Q - - - -
Genfit S a 4 Q - - - -
Gossamer Bio Inc 3 Q - - - -
Green Planet Bioengineering Co Ltd 3 Q - - - -
Gritstone Bio Inc 3 Q - - - -
Galera Therapeutics Inc 3 Q - - - -
Guided Therapeutics Inc 3 Q - - - -
Genethera Inc 3 Q - - - -
G1 Therapeutics Inc 3 Q - - - -
Gtx Corp 2 Q 69.73 % - 13.16 % -
Halozyme Therapeutics Inc 3 Q 83.95 % - 38.61 % 256.3 %
Health Discovery Corporation 3 Q - - - -
Inhibitor Therapeutics Inc 3 Q - - - -
Hst Global Inc 3 Q - - - -
Humacyte Inc 3 Q - - - -
Hydrofarm Holdings Group Inc 3 Q 24.22 % 13.94 % - -
Immunitybio inc 3 Q - - - -
Icosavax Inc 3 Q - - - -
Idera Pharmaceuticals Inc 3 Q - - - 374.79 %
Igm Biosciences Inc 3 Q - - - -
Intelgenx Technologies Corp 3 Q 15.85 % - - -
Ikena Oncology Inc 3 Q - - - -
Inhibikase Therapeutics Inc 3 Q - - - -
Immune Therapeutics Inc 3 Q - - - -
Immunovant Inc 3 Q - - - -
In8bio Inc 3 Q - - - -
Integrated Biopharma Inc 3 Q 11.17 % 4.05 % - 63.18 %
Inhibrx Inc 3 Q - - - -
Infinity Pharmaceuticals Inc 3 Q - - - -
Innovage Holding Corp 3 Q 76.47 % 4.41 % 8.13 % -
Iovance Biotherapeutics inc 3 Q - - - -
Innate Pharma Sa 4 Q - - - -
Iteos Therapeutics Inc 3 Q - 66.79 % - 15.87 %
Iterum Therapeutics Plc 3 Q - 38.24 % - -
Renovacare Inc 3 Q - - - -
Jounce Therapeutics inc 3 Q - - - -
Jasper Therapeutics Inc 3 Q - - - -
Kiromic Biopharma Inc 2 Q - - - -
Krystal Biotech Inc 3 Q - - - -
Purple Biotech Ltd 4 Q - - - 35.2 %
Kymera Therapeutics Inc 3 Q - - - -
Kazia Therapeutics Limited 2 Q - - 57.71 % -
Lineage Cell Therapeutics Inc 3 Q 56.61 % - - -
Atyr Pharma Inc 3 Q - - - -
Lixte Biotechnology Holdings Inc 3 Q - - - -
La Jolla Pharmaceutical Company 3 Q 84.75 % - 6.59 % -
Lazuriton Nano Biotechnology u s a Inc 2 Q - - - -
Livongo Health Inc 2 Q 76.65 % - - 1.36 %
Microbot Medical Inc 3 Q - - - -
Madrigal Pharmaceuticals Inc 3 Q - - - -
Cure Pharmaceutical Holding Corp 3 Q 62.33 % - - -
Momenta Pharmaceuticals inc 2 Q - - - -
Fortium Holdings Corp 3 Q - - - -
Medicure Inc 4 Q 44.19 % - - -
Moderna Inc 3 Q 85.47 % 67.08 % - 121.61 %
Merus N v 3 Q - - - -
Mymd Pharmaceuticals Inc 3 Q - - - -
Mymetics Corporation 3 Q - - - -
Myokardia Inc 3 Q - - - -
Nanovation Microtech Inc 2 Q - - - -
Nanovibronix Inc 3 Q 45.69 % - - -
Nautilus Biotechnology Inc 3 Q - - - -
Nascent Biotech Inc 3 Q - - - -
Neurocrine Biosciences Inc 2 Q 98.93 % 14.64 % 5.33 % -
Neoleukin Therapeutics Inc 3 Q - - - -
Nutra Pharma Corp 3 Q 49.94 % - - -
Nanostring Technologies Inc 3 Q 53.83 % - - -
Novavax inc 3 Q - - - -
Nexien Biopharma Inc 3 Q - - - -
Theralink Technologies Inc 2 Q 75.17 % - - -
Ocugen Inc 3 Q - - - -
Omega Therapeutics Inc 3 Q - - - -
Singular Genomics Systems Inc 3 Q - - - -
Oncternal Therapeutics Inc 3 Q - - - -
Organovo Holdings Inc 3 Q - - - -
Orgenesis Inc 3 Q - - - -
Outlook Therapeutics Inc 3 Q - - - -
Oyster Point Pharma Inc 3 Q - - - -
Palisade Bio Inc 3 Q - - - -
Passage Bio inc 3 Q - - - -
Vaxcyte Inc 3 Q - - - -
Procyon Corp 3 Q 72.42 % 3.57 % - 19.29 %
Petvivo Holdings Inc 3 Q - - - -
Phathom Pharmaceuticals Inc 3 Q - - - -
Biomx Inc 3 Q - - - 65.43 %
Protokinetix Incorporated 3 Q - - - -
Pulse biosciences inc 3 Q - - - -
Protalix Biotherapeutics inc 3 Q 69.28 % - - -
Pharmacyte Biotech Inc 3 Q - - - -
Predictive Oncology Inc 3 Q 64.88 % - - -
Precipio inc 3 Q 23.51 % - - -
Pluristem Therapeutics Inc 3 Q - - - -
Poseida Therapeutics Inc 3 Q - - - -
Proteo Inc 1 Q - - - -
Portage Biotech Inc 1 Q - - - -
Protagonist Therapeutics inc 3 Q - - - -
Pactiv Evergreen Inc 3 Q 7.39 % - 19.87 % -
Pulmatrix Inc 3 Q - - - -
Q Biomed inc 3 Q - - - -
Quest Patent Research Corporation 3 Q - - - -
Qrons Inc 3 Q - - - -
Quanterix Corp 1 Q 60.09 % - - -
Rapt Therapeutics Inc 3 Q - - - -
Vicarious Surgical Inc 3 Q - - - -
Renovacor Inc 3 Q - - - -
Arcus Biosciences Inc 3 Q - - - -
Ridgefield Acquisition Corp 3 Q - - - -
Replimune Group Inc 3 Q - - - -
Reynolds Consumer Products Inc 3 Q 20.11 % 7.29 % 2.32 % 20.04 %
Regen Biopharma Inc 4 Q - - - -
Repligen Corp 3 Q 57.64 % 18.8 % - 7.43 %
Regenxbio Inc 3 Q 54.16 % - - -
Regenerx Biopharmaceuticals inc 3 Q - - - -
Relay Therapeutics Inc 3 Q - - - -
Relmada Therapeutics Inc 3 Q - - - -
Rapid Micro Biosystems inc 3 Q 8.71 % - - -
Royalty Pharma Plc 3 Q 76.47 % 37.86 % - 16.43 %
Respirerx Pharmaceuticals Inc 3 Q - - - -
Rubius Therapeutics inc 3 Q - - - -
Revolution Medicines Inc 3 Q - - - -
Recursion Pharmaceuticals Inc 3 Q - - - -
Sab Biotherapeutics Inc 3 Q - - - -
Strongbridge Biopharma plc 2 Q 95.35 % - - -
Scpharmaceuticals Inc 3 Q - - - -
Sangui Biotech International Inc 3 Q - - - -
Seagen Inc 3 Q 80.51 % - 64.08 % -
Sangamo Therapeutics Inc 3 Q - - 24.77 % -
The Beauty Health Company 3 Q 67.61 % - - -
Skinvisible Inc 3 Q 59.6 % - 7.13 % -
Solid Biosciences Inc 3 Q - - - -
Salarius Pharmaceuticals inc 3 Q - - - -
Sanara Medtech Inc 3 Q 91.11 % - - -
Syndax Pharmaceuticals Inc 3 Q - - 27.41 % -
Soligenix inc 2 Q 4.89 % - - -
Spero Therapeutics Inc 3 Q - - - -
Sqz Biotechnologies Company 3 Q - - - -
Surgalign Holdings Inc 3 Q 66.85 % - - -
Scholar Rock Holding Corp 3 Q - - - -
Surrozen Inc 3 Q - - - -
Neuronetics Inc 3 Q 77.22 % - - -
Satsuma Pharmaceuticals Inc 3 Q - - - -
Surface Oncology Inc 3 Q - - - 8.69 %
Sunwin Stevia International Inc 3 Q - - 0.28 % -
Svf Investment Corp 3 3 Q - - - -
Springworks Therapeutics Inc 3 Q - 32.21 % - -
Talaris Therapeutics Inc 3 Q - - - -
Protara Therapeutics Inc 3 Q - - - -
Tarsus Pharmaceuticals Inc 3 Q 94.76 % - - 6.19 %
Tracon Pharmaceuticals inc 2 Q - - - -
Tscan Therapeutics Inc 3 Q - - - -
Bio techne Corp 3 Q 66.35 % 26.77 % - 11.13 %
Tg Therapeutics inc 3 Q - - - -
Alpha Teknova Inc 3 Q 45.39 % - - -
Twinlab Consolidated Holdings Inc 3 Q 33.07 % - 4.67 % -
Talis Biomedical Corporation 3 Q - - - -
Tenaya Therapeutics Inc 3 Q - - - -
Taysha Gene Therapies Inc 3 Q - - - -
Therapeutic Solutions International Inc 3 Q 78.3 % - 14.76 % -
Unity Biotechnology Inc 3 Q - - - -
Urogen Pharma Ltd 3 Q 89.04 % - - -
Urovant Sciences Ltd 4 Q - - - -
Avricore Health Inc 4 Q - - - -
Vitality Biopharma Inc 2 Q - - - -
Vericel Corporation 3 Q 64.04 % - 8.09 % 0.15 %
Vir Biotechnology Inc 3 Q 92.44 % - - -
Vor Biopharma Inc 3 Q - - - -
Vistagen Therapeutics Inc 3 Q - - - -
Vaxart Inc 3 Q - - - -
Voyager Therapeutics Inc 3 Q - - - -
Windtree Therapeutics Inc 3 Q - - - -
Wave Life Sciences Ltd 3 Q - - - -
Xenetic Biosciences Inc 3 Q - - - -
Acceleron Pharma inc 3 Q - - 0.16 % -
Zai Lab Limited 3 Q 71.78 % - - -
Zymeworks Inc 2 Q - - - -
Profitability
Biotechnology & Pharmaceuticals Industry
Gross margin improved to 72.09 % in 4. Quarter 2021 from 70.34 % in previous quarter, now Ranking #24 and ranking within sector #1.
Net margin for Biotechnology & Pharmaceuticals Industry is 15.84 % above industry average.

More on Biotechnology & Pharmaceuticals Industry Profitability

Biotechnology & Pharmaceuticals Industry achieved cash flow margin of 29.69 % and above average return on equity of 7.94 %

More on Biotechnology & Pharmaceuticals Industry Cash flow
More on Biotechnology & Pharmaceuticals Industry ROE







Cardiovascular Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q




       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VTIQ's Profile

Stock Price

VTIQ's Financials

Business Description

Fundamentals

Charts & Quotes

VTIQ's News

Suppliers

VTIQ's Competitors

Customers & Markets

Economic Indicators

VTIQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071